Medivolve Announces Change of Auditor
Medivolve Announces Change of Auditor
TORONTO, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Medivolve Inc. ("Medivolve" or the "Company") (Cboe CA: MEDV; OTC: MEDVF; FRA:4NC) announces that it has changed auditors from MNP LLP ("MNP") to MS Partners LLP ("MS Partners"), effective February 6, 2024. MNP resigned as of the effective date of January 16, 2024, and MS Partners has been appointed as the successor auditor. In accordance with National Instrument 51‐102 ("NI 51‐102"), the Company has filed a Change of Auditor Notice on SEDAR+ together with letters from both MNP and MS Partners, with each letter confirming agreement with the statements contained in the notice, as applicable. There were no reportable events (as defined in NI 51‐102) between MNP and the Company.
多倫多，2024年2月12日（GLOBE NEWSWIRE）——Medivolve Inc.（“Medivolve” 或 “公司”）（Cboe CA：MEDV；場外交易所：MDVF；FRA: 4NC）宣佈，已將核數師從MNP LLP（“MNP”）改爲MS Partners LLP（“MS Partners”），自2024年2月6日起生效。MNP自2024年1月16日生效之日起辭職，MS Partners被任命爲繼任核數師。根據National Instrument 51‐102（“NI 51‐102”），公司已就SEDAR+提交了審計員變更通知以及MNP和MS Partners的信函，每封信都確認同意通知中包含的聲明（如適用）。MNP與公司之間沒有發生任何應報告的事件（定義見NI 51‐102）。
About Medivolve
關於 Medivolve
Medivolve is a Canadian healthcare technology company headquartered in Toronto, Canada. The Company's mission is to improve health and lives by delivering world-class diagnostic solutions—starting with COVID-19—as well as to enable faster and better care to patients through innovative technology. Medivolve, through its subsidiaries, operates retail patient-care locations in California.
Medivolve是一家加拿大醫療保健技術公司，總部位於加拿大多倫多。該公司的使命是通過提供世界一流的診斷解決方案（從COVID-19開始）來改善健康和生活，並通過創新技術爲患者提供更快、更好的護理。Medivolve通過其子公司在加利福尼亞州經營零售患者護理場所。
For investing inquiries, please contact: David Preiner, CEO, info@medivolve.ca, 702-990-3737.
如需投資諮詢，請聯繫：首席執行官大衛·普雷納，info@medivolve.ca，702-990-3737。